Holdings

Tri Locum Partners LP

As of Sep 30, 2026, Tri Locum Partners LP reported 16 positions worth US$442M. Largest: Vertex Pharmaceuticals Incorporated, Eli Lilly and Company and Teva Pharmaceutical Industries Limited. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Vertex Pharmaceuticals Incorporated133KUS$69.5M−68,895Sep 30, 2026
Eli Lilly and Company51,015US$59M−25,517Sep 30, 2026
Teva Pharmaceutical Industries Limited1.22MUS$48.5M+477KSep 30, 2026
Amneal Pharmaceuticals, Inc.2.33MUS$46.9MnewSep 30, 2026
DexCom, Inc.489KUS$42.2M−331KSep 30, 2026
argenx SE30,399US$29.1M−11,197Sep 30, 2026
Axsome Therapeutics, Inc.143KUS$26.4M−75,970Sep 30, 2026
Johnson & Johnson73,559US$19.5M−351KSep 30, 2026
Enliven Therapeutics, Inc.410KUS$18.8M−456KSep 30, 2026
United Therapeutics Corporation33,000US$17.9M−14,026Sep 30, 2026